We do have COVID-19 IgG/IgM Immunoassay rapid tests to fight the pandemic
0

Tu carrito está vacío

Preventing maternal deaths in 2019

enero 12, 2019

Preventing maternal deaths in 2019

At Maternova, we wanted our first blog of 2019 to focus on something positive that has come out of maternal health advocacy in 2018.

On Friday December 21 2018, H.R.1318 Preventing Maternal Deaths Act was signed into law by the President of the United States. The bill has been in the works for over two years, and amends and expands the Safe Motherhood Initiative within the Centers for Disease Control and Prevention.

It’s no secret that the maternal mortality rates in the USA have been rising, whereas most of the developed world are seeing declining rates. The maternal mortality rate in the USA is around 26.4 deaths per 100,000, whereas most of Western Europe and Canada sees rates below 10 deaths per 100,000. However, the most concerning figure is the maternal mortality rate for black American women, which is 40 per 100,000 compared to 12.4 per 100,000 for white women.

The maternal health dialogue within the USA last year was and still is centered around the high maternal mortality rates in Black women, and rightly so. Being black affects the health and healthcare of pregnant women. Race influences health via various mechanisms, and affects the patient journey starting at research (clinical trials) and development, through to diagnosis and treatment. It transcends all levels and physical boundaries. Although H.R. 1318 allocates funding and resources towards reducing deaths that occur during childbirth and postnatal period, it will need to be channeled into the right areas.

Funding needs to be allocated towards ensuring women get the care they need at the right time, as well as improving the training of health professionals and eliminating existing bias and pre-conceptions when it comes to treating Black patients. However, funding will be incredibly beneficial in racially diverse areas to ensure proper data collection of the outcomes of mothers. Various articles have mentioned the introduction of a confidential enquiry into all maternal deaths, like the one in the UK, which intensely investigates every single maternal death in the country. The investigations are done not to place blame on a single person but to understand the failures of the health system which has led to the deaths of these women. Understanding epidemiology will open up avenues for research and allow targeted approaches when caring for women.

Funding allocated to research can ensure medical research actually includes Black and Hispanic women.   Dr Kacey Eichelberger and colleagues highlighted that the perspectives of current OB/GYNs need to change – there appears to be an acceptance that Black women do worse in studies or are absent from clinical trials, and this is not questioned. This only reinforces the lesser value society has placed on Black lives. Success in trials should look at racially equitable outcomes.

There were many articles produced last year that commented on the genetic predisposition of Black women to disease and poor outcomes in pregnancy, a process called ‘weathering’, whereby environmental and social conditions have affected gene expression, increasing health vulnerability. Although Black women do have a genetic susceptibility to some diseases, it is important for this to not lead to complacency when it comes to addressing structured racism. The interplay of genetic susceptibility and environmental factors is what is killing women. For example, Black women have a higher risk of pre-eclampsia. However, Black women will die from pre-eclampsia if they are not monitored or listened to. The vulnerability of Black women means that the health system should pay even more attention to these women.

Photo credit: Pixabay


Dejar un comentario

Los comentarios se aprobarán antes de mostrarse.


Ver artículo completo

New preeclampsia risk-factor checklists to aid health care providers in identifying pregnant women who may benefit from prophylactic low-dose aspirin
New preeclampsia risk-factor checklists to aid health care providers in identifying pregnant women who may benefit from prophylactic low-dose aspirin

agosto 14, 2020

This past June, the Society for Maternal-Fetal Medicine (SMFM) published in the   American Journal of Obstetrics and Gynecology   a special statement on a collection of two new checklists they created to support health care providers in identifying pregnant women at heightened risk of developing preeclampsia, a major cause of maternal and perinatal morbidity and mortality. 
Ver artículo completo
Are multiple micronutrient supplements superior to the traditional iron-folic acid supplements taken during pregnancy?
Are multiple micronutrient supplements superior to the traditional iron-folic acid supplements taken during pregnancy?

agosto 04, 2020

It is common in low- and middle-income countries for women to experience micronutrient deficiencies as a result of poor diet. This becomes a particularly acute issue in pregnancy due to an increase in the nutrient requirements of both mother and fetus. Deficiencies in micronutrients like vitamin A, iron, iodine, and folate can negatively impact the health of both the mother and fetus.
Ver artículo completo
Studies suggest a potential direct and dose-response relationship between anemia and postpartum hemorrhage
Studies suggest a potential direct and dose-response relationship between anemia and postpartum hemorrhage

julio 20, 2020

Anemia is a concern in pregnancy and is usually addressed with iron supplementation. Its linkage to postpartum hemorrhage has been of concern because those who are anemic are likely to expire more rapidly once blood loss occurs.
Ver artículo completo
Noticias y actualizaciones

Regístrate gratis para obtener lo último en ventas, nuevos lanzamientos y más…

maternal and newborn health news